Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if VIVS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Sentiment: neutral
Last trade: buy 44 days ago
Red flags: 1
24 filers reported a long position in VIVS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $27.8K | 26K | -29.5% |
| RENAISSANCE TECHNOLOGIES LLC | $19.8K | 18.5K | New |
| HRT FINANCIAL LP | $19K | 18.3K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $16.4K | 15.4K | Unchanged |
| BlackRock, Inc. | $12.6K | 11.8K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $7.5K | 7K | Unchanged |
| Tower Research Capital LLC (TRC) | $5.6K | 5.2K | +127.4% |
| SBI Securities Co., Ltd. | $236 | 221 | Unchanged |
| Larson Financial Group LLC | $178 | 166 | Unchanged |
| ALBION FINANCIAL GROUP /UT | $171 | 159 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.